Search Results for 'gemcitabine cisplatin'
-
Search Results
-
Hi everyone,
It is with some sadness that I join the Cholangiocarcinoma Foundation in saying goodbye to the Discussion Board, which is being retired. It has been an honor and a privilege over the past five years to serve as a discussion board moderator, and to interact and share stories with this amazing community.
Your many messages and postings will stay available as a searchable database for current and future patients and caregivers. This database is especially rich in information and experiences regarding traditional treatments such as surgery, gemcitabine/cisplatin chemotherapy and diagnostic tools such as ERCP.
Today, gratefully, there are more and more options for patients. Newer targeted treatments and immunotherapy are making cancer care more individualized. With personalized medicine, however, it becomes harder for patients and caregivers to find others who are having similar experiences, especially for a rare cancer like cholangiocarcinoma. This evolution is pushing our community to look for new and better ways to be sure patients and caregivers find the information they need and have opportunities to interact with others in similar situations.
The Cholangiocarcinoma Foundation remains committed to building these networks. Social media offers opportunities to continue the conversation. The Cholangiocarcinoma Foundation website in its sections for newly diagnosed patients provides links to several active Facebook groups, and its advocates participate in these discussions. The Foundation also offers mentoring resources and monthly support groups for patients and caregivers, to provide opportunities for us to learn from one another. Please take a look at the wealth of resources on the Cholangiocarcinoma Foundation website if you have not visited it recently.
I just passed the seventh anniversary of my own diagnosis. My understanding of this cancer was aided by what I have learned from all of you. Thank you. I will be continuing my work as a volunteer research advocate for the Cholangiocarcinoma Foundation and can be reached at the advocates’ mailbox Advocacy@Cholangiocarcinoma.org.
Take care, regards, Mary
Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery
Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
https://evidence.nejm.org/doi/10.1056/EVIDoa2200015
Thanks to the Massachusetts Medical Society for this piece.
Gavin
I would like to hear from anyone with experience or looking into adding Durvalumab to the standard CCA Gem/Cis chemo treatment. That standard treatment has produced great results for me so far (10 months of treatment) with minimal side effects on my stage 4 cancer. My oncologist and I are discussing whether and how to add in Durvalumab. He is looking into it on his end with other oncologists. I would like to hear from anyone that is doing this or looking into it. I know it’s brand new, and as far as I know there’s no data for adding it to on-going treatment.
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
https://www.clinicaltrials.gov/ct2/show/NCT05285358
Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200015
Thanks to the Massachusetts Medical Society for this piece.
Gavin